Buy GLOW Peptide Pen in Dubai — 70mg Prefilled FlexiPen

Each peptide in the GLOW 70mg Pen is supplied with >99% HPLC for in-vitro laboratory research.

Researchers buy GLOW peptide pen Dubai direct from Remy Peptides (Pinnacle Building, Al Barsha 1) as a 70mg prefilled FlexiPen containing 50mg GHK-Cu, 10mg BPC-157 and 10mg TB-500 — 19 click increments at 2.5mg per click, pre-mixed and pH-balanced so no reconstitution is required. AED 500–600/pen with volume pricing: AED 600 for a single pen, AED 550/pen at 2, and AED 500/pen at 5+, with same-day Dubai dispatch on orders before 4 PM and next-day 2-8°C cold-chain across the other emirates. Finalize on WhatsApp at +351 924 694 686 or via the order page; supplied strictly For Research Use Only under UAE MoHAP Circular 17/2022.

The GLOW 70mg Pen is the prefilled FlexiPen format of the three-compound GLOW research blend: 50mg GHK-Cu (copper peptide), 10mg BPC-157, and 10mg TB-500. The blend is framed around extracellular-matrix, angiogenesis-assay, and cell-migration model endpoints. The pen dispenses 2.5mg per click across 19 click increments, with no reconstitution required. Maintained for in-vitro laboratory research reference under a research-use-only framework.

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a copper-binding tripeptide studied in fibroblast and extracellular-matrix models. Common endpoints include collagen-production markers, lysyl oxidase signalling, and Cu/Zn superoxide dismutase activity. Full GHK-Cu research breakdown →

BPC-157 is a pentadecapeptide derived from a sequence in human gastric juice. In preclinical models it is studied for tissue-repair signalling, VEGF upregulation (a marker used in new-capillary-formation assays), and growth hormone receptor expression. It provides the angiogenesis-assay layer in the GLOW format — pairing vascular-signalling readouts with collagen-synthesis model design. BPC-157 has extensive preclinical data but limited published human trial data; see the peptide interactions and mixing guide for cross-compound handling context.

TB-500 is a synthetic fragment of Thymosin Beta-4 (Tβ4), a protein that sequesters actin monomers to control cytoskeletal dynamics. In preclinical cell-migration models it is studied for keratinocyte and fibroblast migration into matrix-assay regions, plus IL-10 and NF-κB signalling. The standalone TB-500 10mg vial is available where a research protocol needs the fragment isolated from the GHK-Cu and BPC-157 layers of the GLOW stack.

Current pricing for the GLOW 70mg Pen is AED 600 per pen, AED 1,100 for a 2-pack (AED 550/pen), and AED 2,500 for a 5+ pack (AED 500/pen). The pen ships under a research-use-only and cold-chain handling framework.

Use the secure order flow to place GLOW in cart and continue through the UAE delivery route under research-use-only handling.

GHK-Cu and the full GLOW formulation are framed under UAE MoHAP Circular 17/2022 for in-vitro laboratory research use only. They are not approved for human consumption, therapeutic use, or veterinary use. The page covers research reference. See our UAE research peptide compliance guide for full detail.

Store the prefilled GLOW 70mg Pen refrigerated at 2–8°C from arrival through use. Do not freeze and protect from direct light. The pen ships under cold-chain logistics with temperature indicators. Each box includes the pen and 10 pen dispensing needles — no reconstitution required, no bacteriostatic water needed. For broader context, see the peptide stability and storage guide, the HPLC purity guide, and the bacteriostatic water reconstitution guide.

Yes. GLOW 70mg Pen is supplied strictly for in-vitro laboratory research under UAE MoHAP Circular 17/2022. Not for human or veterinary use.

The GLOW 70mg Pen packages the three-compound stack (50mg GHK-Cu + 10mg BPC-157 + 10mg TB-500) in a prefilled, pH-balanced FlexiPen body that dispenses 2.5mg per click across 19 clicks. It requires no bacteriostatic water and no reconstitution step, and it ships cold-chain from Dubai stock for research use only.

The GLOW blend (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg) is a multi-pathway research format where each component covers a distinct ECM-remodeling or tissue-repair pathway: GHK-Cu for copper-binding and fibroblast research, BPC-157 for angiogenesis and cytoprotection, TB-500 for actin-binding and migration. The pen format is referenced in research workflows that need consistent micro-doses from a single delivery rather than three separate vial reconstitutions. Supplied as a 70mg-equivalent reference pen for in-vitro laboratory research only.